Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT07317206
Ayahuasca, Esketamine and PTSD
Effects of Single Dose of Ayahuasca or Esketamine on Posttraumatic Stress Disorder: a Randomized, Double-blinded Study
Sponsor: University of Sao Paulo
Conditions
Posttraumatic Stress Disorder (PTSD)
Interventions
Ayahuasca Esketamine
Updated 1 time since 2026 Last updated: Dec 19, 2025 Started: Dec 20, 2025 Primary completion: Jun 30, 2026 Completion: Jul 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07317206, this PHASE2 trial focuses on Posttraumatic Stress Disorder (PTSD) and remains actively recruiting participants. Sponsored by University of Sao Paulo, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University of Sao Paulo
Data source: University of Sao Paulo
For direct contact, visit the study record on ClinicalTrials.gov .